NO2914264T3 - - Google Patents

Info

Publication number
NO2914264T3
NO2914264T3 NO13776720A NO13776720A NO2914264T3 NO 2914264 T3 NO2914264 T3 NO 2914264T3 NO 13776720 A NO13776720 A NO 13776720A NO 13776720 A NO13776720 A NO 13776720A NO 2914264 T3 NO2914264 T3 NO 2914264T3
Authority
NO
Norway
Application number
NO13776720A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2914264T3 publication Critical patent/NO2914264T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO13776720A 2012-11-02 2013-10-04 NO2914264T3 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12007494 2012-11-02
EP13776720.8A EP2914264B1 (en) 2012-11-02 2013-10-04 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)
PCT/EP2013/002998 WO2014067610A1 (en) 2012-11-02 2013-10-04 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of hepatocellular carcinoma (hcc)

Publications (1)

Publication Number Publication Date
NO2914264T3 true NO2914264T3 (https=) 2018-01-06

Family

ID=47143496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13776720A NO2914264T3 (https=) 2012-11-02 2013-10-04

Country Status (26)

Country Link
US (1) US20150283137A1 (https=)
EP (1) EP2914264B1 (https=)
JP (1) JP6255028B2 (https=)
KR (1) KR102131588B1 (https=)
CN (1) CN104768553A (https=)
AR (1) AR093318A1 (https=)
AU (1) AU2013339823B2 (https=)
BR (1) BR112015008279A2 (https=)
CA (1) CA2890273C (https=)
DK (1) DK2914264T3 (https=)
ES (1) ES2646913T3 (https=)
HK (1) HK1211869A1 (https=)
HR (1) HRP20171295T1 (https=)
HU (1) HUE035483T2 (https=)
IL (1) IL238536B (https=)
LT (1) LT2914264T (https=)
MX (1) MX354518B (https=)
NO (1) NO2914264T3 (https=)
PL (1) PL2914264T3 (https=)
PT (1) PT2914264T (https=)
RS (1) RS56485B1 (https=)
RU (1) RU2650679C2 (https=)
SG (1) SG11201503214YA (https=)
SI (1) SI2914264T1 (https=)
WO (1) WO2014067610A1 (https=)
ZA (1) ZA201503924B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014307556B2 (en) 2013-08-14 2018-04-26 Yugenkaisha Japan Tsusyo Hydroponic culture system, and plant factory provided with hydroponic culture system and greenhouse produced from styrene foam
KR20220034183A (ko) * 2019-07-10 2022-03-17 메르크 파텐트 게엠베하 약제학적 제제
WO2021076444A1 (en) 2019-10-14 2021-04-22 Olatec Therapeutics Llc Methods for treating breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
SI2373640T1 (sl) * 2009-01-08 2014-11-28 Merck Patent Gmbh Nove polimorfne oblike hidrokloridne soli 3-(1-(3-(5-(1-metil-piperidin-4ilmetoksi)-pirimidin-2-il)-benzil)-6- okso-1,6-dihidro-piridazin-3-il)-benzonitrila in postopki proizvodnje le-teh

Also Published As

Publication number Publication date
JP2015536957A (ja) 2015-12-24
AU2013339823A1 (en) 2015-06-18
RU2650679C2 (ru) 2018-04-17
IL238536B (en) 2019-01-31
CN104768553A (zh) 2015-07-08
CA2890273A1 (en) 2014-05-08
RU2015120692A (ru) 2016-12-27
SG11201503214YA (en) 2015-05-28
HK1211869A1 (en) 2016-06-03
MX2015005265A (es) 2015-07-17
US20150283137A1 (en) 2015-10-08
ES2646913T3 (es) 2017-12-18
EP2914264B1 (en) 2017-08-09
BR112015008279A2 (pt) 2017-07-04
HUE035483T2 (hu) 2018-05-02
KR20150079942A (ko) 2015-07-08
SI2914264T1 (sl) 2017-12-29
LT2914264T (lt) 2017-11-10
CA2890273C (en) 2021-10-26
DK2914264T3 (en) 2017-09-11
HRP20171295T1 (hr) 2017-10-20
KR102131588B1 (ko) 2020-07-08
RS56485B1 (sr) 2018-01-31
PT2914264T (pt) 2017-11-14
ZA201503924B (en) 2020-11-25
PL2914264T3 (pl) 2017-12-29
JP6255028B2 (ja) 2017-12-27
EP2914264A1 (en) 2015-09-09
MX354518B (es) 2018-03-08
AR093318A1 (es) 2015-05-27
WO2014067610A1 (en) 2014-05-08
IL238536A0 (en) 2015-06-30
AU2013339823B2 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
BR112014024221A2 (https=)
BR112014017659A2 (https=)
BR112014017592A2 (https=)
BR112014017607A2 (https=)
BR112014017646A2 (https=)
BR112014024833A2 (https=)
AR092201A1 (https=)
BR112014019268A2 (https=)
BR112013027865A2 (https=)
BR112014018938A2 (https=)
BR112014018300A2 (https=)
BR112014017647A2 (https=)
BR112014017588A2 (https=)
BR112014013184A8 (https=)
BR112014018782A2 (https=)
BR112014017627A2 (https=)
BR112014017652A2 (https=)
BR112014019282A2 (https=)
BR112014017808A2 (https=)
BR112014017671A2 (https=)
BR112014017589A2 (https=)
BR112014018166A2 (https=)
BR112014017989A2 (https=)
BR112014017667A2 (https=)
BR112014017600A2 (https=)